Carbidopa And Levodopa Extended-Release Tablets
Item Name Code (INC) 47567
![]() |
Additional Information for Carbidopa And Levodopa Extended-Release Tablets
Carbidopa and Levodopa Extended-Release Tablets are medications used to treat the symptoms of Parkinson's disease. They belong to the supply class Drugs and Biologicals in the supply group Medical, Dental, and Veterinary Equipment and Supplies.
Carbidopa and Levodopa are both active ingredients in this medication. Levodopa is converted into dopamine in the brain, which helps to improve motor function and reduce symptoms such as tremors, stiffness, and difficulty with movement. Carbidopa is added to the medication to enhance the effectiveness of Levodopa by preventing its breakdown in the bloodstream before it reaches the brain.
The extended-release formulation of these tablets allows for a slow and steady release of the medication over time, providing a more consistent effect and reducing the frequency of dosing throughout the day.
It is important to note that Carbidopa and Levodopa Extended-Release Tablets should only be used under the supervision and prescription of a healthcare professional, as they may have potential side effects and interactions with other medications.
Related Item Names for INC 47567 Carbidopa And Levodopa Extended-Release Tablets
NATO Stock Numbers with Item Name 47567 Carbidopa And Levodopa Extended-Release Tablets Page 1 of 1
- NDC00056-0521-28
- RNCC: 3 | RNVC: 2 | DAC: 4
- NDC00006-3919-68
- RNCC: 3 | RNVC: 2 | DAC: 1
- 3400933569389
- RNCC: 3 | RNVC: 2 | DAC: 4
- 3400933566548
- RNCC: 3 | RNVC: 2 | DAC: 4
- HAL274K
- RNCC: 5 | RNVC: 2 | DAC: 4